These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 19894674

  • 1. Fragment-based prediction of the clinical occurrence of long QT syndrome and torsade de pointes.
    Clark M, Wiseman JS.
    J Chem Inf Model; 2009 Nov; 49(11):2617-26. PubMed ID: 19894674
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S, Marte F, Di Bella G, Currò A, Coglitore S.
    Int J Cardiol; 2008 Nov 12; 130(2):e71-3. PubMed ID: 18255176
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M, Coppa F, Cappucciati C, Brambilla P, d'Allio G, Caverzasi E, Barale F, De Ferrari GM.
    Curr Opin Investig Drugs; 2006 Mar 12; 7(3):256-63. PubMed ID: 16555686
    [Abstract] [Full Text] [Related]

  • 6. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Antzelevitch C, Sun ZQ, Zhang ZQ, Yan GX.
    J Am Coll Cardiol; 1996 Dec 12; 28(7):1836-48. PubMed ID: 8962574
    [Abstract] [Full Text] [Related]

  • 7. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.
    Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W.
    Europace; 2014 Jan 12; 16(1):101-8. PubMed ID: 23833046
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome.
    Noda T, Shimizu W, Satomi K, Suyama K, Kurita T, Aihara N, Kamakura S.
    Eur Heart J; 2004 Dec 12; 25(23):2149-54. PubMed ID: 15571831
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Torsade de pointes].
    Haverkamp W, Hördt M, Chen X, Hindricks G, Willems S, Kottkamp H, Rotman B, Brunn J, Borggrefe M, Breithardt G.
    Z Kardiol; 1993 Dec 12; 82(12):763-74. PubMed ID: 8147050
    [Abstract] [Full Text] [Related]

  • 15. Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs.
    Hondeghem LM.
    J Cardiovasc Electrophysiol; 2006 Mar 12; 17(3):337-40. PubMed ID: 16643415
    [Abstract] [Full Text] [Related]

  • 16. QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.
    Recanatini M, Poluzzi E, Masetti M, Cavalli A, De Ponti F.
    Med Res Rev; 2005 Mar 12; 25(2):133-66. PubMed ID: 15389727
    [Abstract] [Full Text] [Related]

  • 17. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K, Dorian P.
    Europace; 2007 Sep 12; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The mechanism of pause-induced torsade de pointes in long QT syndrome.
    Liu J, Laurita KR.
    J Cardiovasc Electrophysiol; 2005 Sep 12; 16(9):981-7. PubMed ID: 16174020
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.